This policy document is part of a response submitted by the Progress Educational Trust (PET) to the Human Fertilisation and Embryology Authority's Consultation on its 8th Code of Practice and Revised Consent Forms.
Do you think that new guidance on costed treatment plans in the Code of Practice will help clinics make costs more transparent for patients, while acknowledging that medical treatments are not entirely predictable?
While we welcome costed treatment plans, a balance needs to be struck between making them as clear as possible for patients, and not making them unnecessarily onerous for clinics to produce. Costed treatment plans would lend themselves to being generically produced, so should not be problematic for clinics.
These plans should clearly indicate to patients that their treatment costs may increase if additional procedures become clinically necessary. If a clinic finds that it is regularly exceeding the total estimated cost in the treatment plan, it should review its procedure.